Table 1 Demographic data of neuromuscular scoliosis in the three groups.

From: Clinical and radiological efficacy of spino-pelvic fixation in the treatment of neuromuscular scoliosis

Variables

Pelvic fixation (Group A) (N = 16)

Fixed to S1 (Group B) (N = 33)

Fixed to L5 (Group C) (N = 28)

P-value

Sex (M:F)

13:3

20:13

16:12

0.248

Age (years)

19.3 ± 8.4*

17.3 ± 8.2*

18.0 ± 7.2*

0.713

BMI (kg/m2)

18.7 ± 3.4*

17.6 ± 3.2*

18.2 ± 2.9*

0.560†

Cause (n)

0.100$

 SMD/DMD

11 (68.8%)

13 (39.4%)

6 (21.4%)

 

 Cerebral palsy

5 (31.4%)

16 (48.4%)

15 (53.7%)

 

 Syndromic NMDs

0

2 (6.1%)

2 (7.1%)

 

 Spinal cord injury

0

0

2 (7.1%)

 

 Others

0

2 (6.1%)

3 (10.7%)

 

Hospital stay (day)

27.3 ± 24.2*

22.1 ± 12.6*

33.8 ± 43.0*

0.304

Operative time (min)

335.0 ± 65.0*

284.1 ± 66.0*

291.1 ± 63.8*

0.035

Bleeding loss (mL)

4237.5 ± 1833.7*

3275.8 ± 2552.3*

1978.6 ± 1278.1*

0.002

Fusion level

15.8 ± 0.4*

15.3 ± 1.2*

14.3 ± 1.4*

 < 0.001†

Osteotomy

0

1

1

 
  1. P-values are calculated by Chi-square test.
  2. Post-hoc analysis by Bonferroni test on 95% confidence level is performed regarding operative time.
  3. Group A vs Group B: P = 0.036, Group A vs Group C: P = 0.103, Group B vs Group C: P = 1.00.
  4. Post-hoc analysis by Bonferroni test on 95% confidence level is performed regarding bleeding loss.
  5. Group A vs Group B: P = 0.369, Group A vs Group C: P = 0.002, Group B vs Group C: P = 0.044.
  6. Post-hoc analysis by Bonferroni test on 95% confidence level is performed regarding fusion level.
  7. Group A vs Group B: P = 0.516, Group A vs Group C: P < 0.001, Group B vs Group C: P = 0.005.
  8. N number, M male, F female, BMI body mass index, SMD spinal muscular dystrophy, DMD Duchenne muscular dystrophy, NMD neuromuscular disorder.
  9. *Data represent mean ± standard deviation values for each group.
  10. †P-values are calculated by one-way ANOVA test.
  11. $P-value is calculated by Fisher’s exact test.
Back to article page